FDA Inspection 1093554 — Lotte Biologics USA, LLC

Lotte Biologics USA, LLC — FEI 1317757

The FDA completed an inspection of Lotte Biologics USA, LLC on June 5, 2019 in East Syracuse, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Syracuse, NY (United States)